Skip to main content
Log in

Comparative induction of cytochrome P450IVA1 and peroxisome proliferation by ciprofibrate in the rat and marmoset

  • Original Investigations
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

Chronic ciprofibrate administration resulted in distinct differences in hepatic responses between the two species examined. In the rat, hepatomegaly was observed with the coordinate induction of carnitine acetyltransferase, peroxisomal β-oxidation and cytochrome P450IVA1 activities. The latter induction of cytochrome P450IVA1-dependent fatty acid hydroxylase activity was specific to this cytochrome P450 sub family, as ciprofibrate pretreatment resulted in an inhibition of the enzyme activities associated with the cytochrome P450 IIB and IA sub-families. Induction of mitochondrial enzymes were also noted in the rat, but at a substantially lower level than the microsomal and peroxisomal enzyme changes noted above. The majority of these enzyme changes were reversible in the rat after a 4-week, inducer-free period. In contrast, the marmoset displayed a different pattern of enzyme changes in response to ciprofibrate and at the high dose level, inhibition of microsomal fatty acid hydroxylase activity was observed in addition to no change in carnitine acetyltransferase activitiy. Although peroxisomal β-oxidation activity was induced in the marmoset, the specific activity was 10-fold lower than in the rat, concomitant with only minimum changes in the liver: body weight ratio. Taken collectively, our data have demonstrated that the marmoset is relatively refractory to ciprofibrate-induced liver enzyme changes with the implication that the extrapolation of the associated hepatotoxicity clearly documented in rodents must be viewed with extreme caution in non-human primates.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Allen KL, Green CE, Tyson CA (1987) Comparative studies of peroxisomal enzyme induction in hepatocytes from rat, cynomolgus monkey and human by hypolipidaemic drugs. Toxicologist 7: 63 (abstract)

    Google Scholar 

  • Awasthi YC, Beutler E, Srivastava SK (1975) Purification and properties of human erythrocyte glutathione peroxidase. J Biol Chem 250: 5144–5149

    PubMed  Google Scholar 

  • Beaufay H, Bendall DS, Baudhuin P, Wattiaux R, De Duve C (1959) Tissue fractionation studies. Analysis of mitochondrial fractions from rat liver by density-gradient centrifugation. Biochem J 73: 628–637

    PubMed  Google Scholar 

  • Beckett RB, Weiss R, Stitzel RE, Cenedella RJ (1972) Studies on the hepatomegaly caused by the hypolipidaemic drugs nafenopin and clofibrate. Toxicol Appl Pharmacol 23: 42–53

    Article  PubMed  Google Scholar 

  • Bieber LL, Abraham T, Helmrath T (1972) A rapid spectrophotometric assay for carnitine palmitoyltransferase. Anal Biochem 50: 509–518

    Article  PubMed  Google Scholar 

  • Blumcke S, Schwartzkopff W, Lobeck H, Edmondson NA, Prentice DE, Blane GF (1983) Influence of fenofibrate on cellular and subcellular liver structure in hyperlipidaemic patients. Atherosclerosis 46: 105–116

    Article  PubMed  Google Scholar 

  • Bock PP, Kramar R, Pavelka M (1980) Peroxisomes and related particles. Cell Biology Monographs 7: 44–74. Springer-Verlag, Berlin

    Google Scholar 

  • Bronfman M, Inestrosa NC, Leighton F (1979) Fatty acid oxidation by human liver peroxisomes. Biochem Biophys Res Commun 88: 1030–1036

    Article  PubMed  Google Scholar 

  • Burke MD, Prough RA, Mayer RT (1977) Characteristics of a microsomal cytochrome P-448 mediated reaction. Ethoxyresorufin-O-deethylation. Drug Metab Dispos 5: 1–8

    PubMed  Google Scholar 

  • Challiner MR, Park BK, Odum J, Orton TC, Parker GL (1980) The effects of phenobarbitone on urinary 6β-hydroxycortisol excretion and hepatic enzyme activity in the marmoset monkey (Callithru jacchus). Biochem Pharmacol 29: 3319–3324

    Article  PubMed  Google Scholar 

  • Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochem J 18: 5294–5299

    Article  Google Scholar 

  • Christen P, Peacock WC, Christen AE, Wacker WEC (1970) Urate oxidase in primate phylogenesis. Eur J Biochem 12: 3–5

    Article  PubMed  Google Scholar 

  • Cohen AJ, Grasso P (1981) Review of the hepatic response to hypolipidaemic drugs in rodents and assessment of its toxicological significance to man. Food Cosmet Toxicol 19: 585–605

    Article  PubMed  Google Scholar 

  • Davison C, Benziger D, Fritz A, Edelson J (1975) Absorption and disposition of 2-(4-(2,2-dichlorocyclopropyl)phenoxy)-2-methylpropanoic acid, WIN 35, 833 in rats, monkeys and man. Drug Metab Dispos 3: 520–524

    PubMed  Google Scholar 

  • Eacho PI, Foxworthy PS, Johnson WD, Hoover DM, White SL (1986) Hepatic peroxisomal changes induced by a tetrazole-substituted alkoxyacetophenone in rats and comparison with other species. Toxicol Appl Pharmacol 83: 430–437

    Article  PubMed  Google Scholar 

  • Earnshaw D, Dale JW, Goldfarb PS, Gibson GG (1988) Differential splicing in the 3′ non-coding region of rat cytochrome P-452 (P450IVA1) mRNA. Febs Lett 236: 357–361

    Article  PubMed  Google Scholar 

  • Edelson J, Benziger DP, Arnold A, Beyler AL (1979) Blood levels, tissue distribution and the duration of action in rats of ciprofibrate, a new hypolipidaemic agent. Atherosclerosis 33: 351–357

    PubMed  Google Scholar 

  • Elcombe CR (1985) Species differences in carcinogenicity and peroxisome proliferation due to trichloroethylene. A biochemical human hazard assessment. Arch Toxicol 8 [Suppl]: 6–17

    Google Scholar 

  • Elcombe CR, Mitchell AM (1986) Peroxisome proliferation due to di-(2-ethylhexyl)phthalate (DEHP): species differences and possible mechanisms. Environ Health Pers 70: 211–219

    Google Scholar 

  • Elcombe CR, Styles JA (1989) Species differences in peroxisome proliferation. Toxicologist 9: Abstract no. 249

  • Emudianughe TS, Caldwell J, Sinclair KA, Smith RL (1983) Species differences in the metabolic conjugation of clofibric acid and clofibrate in laboratory animals and man. Drug Metab Dispos 11: 97–102

    PubMed  Google Scholar 

  • Gariot P, Pointel JP, Barrat E, Drouin D, Debry G (1984) Etude morophometrique des peroxysomes hepatiques chez des malades hyperlipoproteinemiques traites par fenofibrate. Biomed Pharmacother 38: 101–106

    PubMed  Google Scholar 

  • Goldenberg H, Huttinger M, Kampfer P, Kramar R, Pavelka M (1976) Effect of clofibrate application on morphology and enzyme content of liver peroxisomes. Histochemistry 46: 189–196

    PubMed  Google Scholar 

  • Hanefeld M, Kemmer C, Kadner E (1983) Relationship between morphological changes and lipid lowering action ofp-chlorophenoxy-isobutyric acid (CPIB) on hepatic mitochondria and peroxisomes in man. Atherosclerosis 46: 239–246

    PubMed  Google Scholar 

  • Hawkins JM, Jones WE, Bonner FW, Gibson GG (1987) The effect of peroxisome proliferators on microsomal, peroxisomal and mitochondrial enzyme activities in the liver and kidney. Drug Metab Rev 18: 441–515

    PubMed  Google Scholar 

  • Kluwe WM, Haseman JK, Fielding D, Douglas J, Huff JE (1982) The carcinogenicity of dietary di-(2-ethylhexyl)phthalate (DEHP) in Fischer 344 rats and B6C3F1 mice. J Toxicol Environ Health 10: 797–815

    PubMed  Google Scholar 

  • Krajl M (1965) A rapid microfluorimetric determination of monoamine oxidase. Biochem Pharmacol 14: 1683–1685

    Article  Google Scholar 

  • Lake BG, Evans JG, Gray TJB, Korosi SA, North CJ (1989) Comparative studies on nafenopin-induced hepatic peroxisome proliferation in the rat, Syrian hamster, guinea pig and marmoset. Toxicol Appl Pharmacol 99: 148–160

    Article  PubMed  Google Scholar 

  • Lalwani ND, Reddy MK, Qureshi SA, Reddy JK (1981) Development of hepatocellular carcinomas and increased peroxisomal fatty acid β-oxidation in rats fed 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio acetic acid (Wy-14, 643) in the semipurified diet. Carcinogenesis 2: 645–650

    PubMed  Google Scholar 

  • Lalwani ND, Reddy MK, Qureshi SA, Sirtori CR, Abiko Y, Reddy JK (1983) Evaluation of selected hypolipidaemic agents for the induction of peroxisomal enzymes and peroxisome proliferation in the rat liver. Hum Toxicol 2: 27–48

    PubMed  Google Scholar 

  • Lazarow PB (1982) Compartmentation of β-oxidation of fatty acids in peroxisomes. In: Sies H. (ed) Metabolic compartmentation. Academic Press, New York, pp 317–329

    Google Scholar 

  • Lazarow PB, Shio H, Leroy-Houyet MA (1982) Specificity in the action of hypolipidaemic drugs: increase of peroxisomal β-oxidation largely dissociated from hepatomegaly and peroxisome proliferation in the rat. J Lipid Res 23: 317–326

    PubMed  Google Scholar 

  • Lee YP, Lardy HA (1965) Influence of thyroid hormones onl-α-glycerophosphate dehydrogenases and other dehydrogenases in various organs of the rat. J Biol Chem 240: 1427–1436

    PubMed  Google Scholar 

  • Lee YP, Takemori AE, Lardy H (1959) Enhanced oxidation of α-glycerophosphate by mitochondria of thyroid hormone fed rats. J Biol Chem 234: 3051–3054

    PubMed  Google Scholar 

  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275

    PubMed  Google Scholar 

  • Mann AH, Price SC, Mitchell FE, Grasso P, Hinton RH, Bridges JW (1985) Comparison of the short-term effects of di-(2-ethyl-hexyl)phthalate, di-(n-hexyl)phthalate and di-(noctyl)phthalate in rats. Toxicol Appl Pharmacol 77: 116–132

    Article  PubMed  Google Scholar 

  • Nash T (1953) The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochem J 55: 416–421

    PubMed  Google Scholar 

  • Omura T, Sato R (1964) The carbon monoxide-binding pigment of liver microsomes. 1. Evidence for its haemoprotein nature. J Biol Chem 239: 2370–2378

    PubMed  Google Scholar 

  • Orton TC, Parker GL (1982) The effect of hypolipidemic agents on the hepatic microsomal drug-metabolising enzyme system of the rat. Induction of cytochrome(s) P-450 with specificity towards terminal hydroxylation of lauric acid. Drug Metab Dispos 10: 110–115

    PubMed  Google Scholar 

  • Orton TC, Adam HK, Bentley M, Holloway B, Tucker MJ (1984) Clobuzarit: species differences in the morphological and biochemical response of the liver following chronic administration. Toxicol Appl Pharmacol 73: 138–151

    Article  PubMed  Google Scholar 

  • Parker GL, Orton TC (1980) Induction of oxyisobutyrates of hepatic and kidney microsomal cytochrome P-450 with specificity towards hydroxylation of fatty acids. In: Gustafsson JA, Carlstedt-Duke J, Mode A, Rafter J (eds). Biochemistry biophysics and regulation of cytochrome P-450. Elsevier, Amsterdam, pp 373–377

    Google Scholar 

  • Prospero TD (1974) A simplified assay for succinate dehydrogenase. Method Developments in Biochemistry 4: 411–412

    Google Scholar 

  • Reddy JK, Lalwani ND (1983) Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidaemic drugs and industrial plasticisers to humans. CRC Crit Rev Toxicol 12: 1–58

    Google Scholar 

  • Reddy JK, Bunyaratvej S, Svoboda D (1969) Microbodies in experimentally altered cells. IV. Acatalasemic (CSb) mice treated with clofibrate. J Cell Biol 42: 587–596

    Article  PubMed  Google Scholar 

  • Reddy JK, Azarnoff DL, Hignite CE (1980) Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature 283: 397–398

    Article  PubMed  Google Scholar 

  • Reddy, JK, Lalwani ND, Qureshi SA, Reddy MK, Moehle CM (1984) Induction of hepatic peroxisome proliferation in non-rodent species including primates. Am J Pathol 114: 171–183

    PubMed  Google Scholar 

  • Sharma R, Lake BG, Foster J, Gibson GG (1988a) Microsomal cytochrome P-452 induction and peroxisomal proliferation by hypolipidaemic agents in rat liver: a mechanistic inter-relationship. Biochem Pharmacol 37: 1193–1201

    Article  PubMed  Google Scholar 

  • Sharma R, Lake BG, Gibson GG (1988b) Co-induction of microsomal cytochrome P-452 and the peroxisomal fatty acid β-oxidation pathway in the rat by clofibrate and di-(2-ethylhexyl)phthalate: dose-response studies. Biochem Pharmacol 37: 1203–1206

    Article  PubMed  Google Scholar 

  • Svoboda DJ, Azarnoff DL (1966) Response of hepatic microbodies to a hypolipidaemic agent, ethylchlorophenoxyisobutyrate (CPIB). J Cell Biol 30: 442–450

    Article  PubMed  Google Scholar 

  • White BA, Bancroft FC (1982) Cytoplasmic dot hybridisation. Simple analysis of relative mRNA levels in multiple small cell or tissue samples. J Biol Chem 257: 8569–8572

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Makowska, J.M., Bonner, F.W. & Gibson, G.G. Comparative induction of cytochrome P450IVA1 and peroxisome proliferation by ciprofibrate in the rat and marmoset. Arch Toxicol 65, 106–113 (1991). https://doi.org/10.1007/BF02034935

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02034935

Key words

Navigation